PostEra, founded with the mission to revolutionize medicinal chemistry through machine learning, aims to accelerate drug discovery and bring more cures to patients. The company leverages advanced AI technologies to streamline the Design-Make-Test cycle in medicinal chemistry. PostEra offers services that include advancing small molecule programs through partnerships with biopharma companies and developing its own internal drug pipeline. Their market focus spans collaborations with major pharmaceutical companies and research institutions.
Notable figures associated with PostEra include Aaron Morris. The company has raised $26 million from top investors and secured $1 billion in AI partnerships, including multi-year agreements with industry giants like Amgen, Pfizer, and the NIH. PostEra also spearheaded the world's largest open-science drug discovery initiative. These achievements underscore PostEra's significant impact on the biopharma industry, positioning it as a leader in AI-driven drug discovery.
